We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Editas Medicine said Tuesday that CEO Katrine Bosley has decided to step down from her role effective March 1, with board member Cynthia Collins appointed to the position on an interim basis.
Editas Medicine said Tuesday that CEO Katrine Bosley has decided to step down from her role effective March 1, with board member Cynthia Collins appointed to the position on an interim basis.